abbvie glp 1 Novo pressures GLP-1 compounders as FDA ban takes hold ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT

Five scientists won this years Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for diabetes and obesity.

The FDA has approved three GLP-1 receptor agonist drugs for weight loss

Its about to get a lot harder to get cheap GLP-1s: Rising costs may force consumers to cut back on discretionary spending, creating headwinds for retailers already fearing tariff-driven cost increases.

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

Not for human or veterinary use